Barbosa I C, Coutinho E, Hirsch C, Ladipo O A, Olsson S E, Ulmsten U
Maternidade Climério de Oliveira, Federal University of Bahia, Brazil.
Contraception. 1996 Oct;54(4):213-7. doi: 10.1016/s0010-7824(96)00191-6.
This study was undertaken to determine the time required by a single implant containing nomegestrol acetate to affect cervical mucus production and sperm penetration in women. All subjects were investigated and, if necessary, treated for any kind of cervicitis or vaginitis prior to starting cervical mucus study. The subjects had not used hormonal contraception for at least three months prior to investigation. They were counseled to use condoms during this study and also to refrain from intercourse during the period of cervical mucus sampling. Follicular development and endometrial thickness were analyzed by transvaginal sonography. Cervical mucus examination, sperm penetration test, and transvaginal sonography were performed during the control cycle and during the first cycle of Uniplant use. Blood samples were taken for the measurement of estradiol, LH, and progesterone. Cervical mucus and sperm penetration tests were evaluated according to the World Health Organization (WHO) criteria. In the treated cycle, when cervical mucus reached a score of 8-10, Uniplant was inserted, independent of the day of the cycle. Cervical mucus was then collected at 0, 4, 8, 12, 24, 48, and 96 h later until a marked change in volume, consistency, ferning spinnbarkheit, and cellularity was observed. All samples were also used for sperm penetration test. Preovulatory estradiol and LH peak decreased significantly compared to pre-implant insertion. Progesterone levels were within the normal limit. Cervical mucus and sperm penetration tests were not affected by Uniplant in the first 12 h. Twenty-four hours after Uniplant insertion, cervical mucus and sperm penetration tests were affected in 70.6% of the women. Forty-eight hours after implant insertion, the women were affected. Follicular rupture occurred in the majority of the women 48 h after implant insertion. Based on these results, it is possible to conclude that Uniplant can affect estradiol and LH preovulatory peaks and disrupt the process of cervical mucus production and sperm penetration, but it was unable to prevent ovulation when inserted in the preovulatory phase.
本研究旨在确定含醋酸诺美孕酮的单一植入剂对女性宫颈黏液分泌和精子穿透所需的时间。在开始宫颈黏液研究之前,对所有受试者进行了调查,如有必要,对任何类型的宫颈炎或阴道炎进行了治疗。受试者在调查前至少三个月未使用激素避孕方法。建议他们在本研究期间使用避孕套,并在宫颈黏液取样期间避免性交。通过经阴道超声检查分析卵泡发育和子宫内膜厚度。在对照周期和使用Uniplant的第一个周期期间进行宫颈黏液检查、精子穿透试验和经阴道超声检查。采集血样以测量雌二醇、促黄体生成素和孕酮。根据世界卫生组织(WHO)标准评估宫颈黏液和精子穿透试验。在治疗周期中,当宫颈黏液评分为8 - 10分时,无论周期的哪一天,均插入Uniplant。然后在0、4、8、12、24、48和96小时后收集宫颈黏液,直到观察到体积、稠度、羊齿状结晶、拉丝度和细胞成分有明显变化。所有样本也用于精子穿透试验。与植入前相比,排卵前雌二醇和促黄体生成素峰值显著降低。孕酮水平在正常范围内。在最初12小时内,Uniplant对宫颈黏液和精子穿透试验没有影响。插入Uniplant 24小时后,70.6%的女性宫颈黏液和精子穿透试验受到影响。植入后48小时,这些女性受到影响。大多数女性在植入后48小时发生卵泡破裂。基于这些结果,可以得出结论,Uniplant可以影响排卵前雌二醇和促黄体生成素峰值,并干扰宫颈黏液产生和精子穿透的过程,但在排卵前期插入时无法阻止排卵。